Results 101 to 110 of about 3,130,306 (355)

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Flow in a model turbine stator [PDF]

open access: yes
In view of the complex nature of the flowfield in the hot section of gas turbine engines, the need to predict heat transfer and flow losses, the possible appearance of separation and strong secondary flows, etc., the present effort is focusing upon a ...
Briley, W. R.   +2 more
core   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Thermal Fluid Flow Transport Phenomenon in Unsteady Rotating Drum during Spin-Down Process

open access: yesInternational Journal of Rotating Machinery, 2005
Numerical analysis is performed on unsteady-state thermal fluid flow transport phenomena in a rotating drum heated at constant wall temperature during a spin-down process.
Shuichi Torii, Wen-Jei Yang
doaj   +1 more source

Mean velocities and Reynolds stresses in a juncture flow [PDF]

open access: yes
Values of three mean velocity components and six turbulence stresses measured in a juncture flow are presented and discussed. The juncture flow is generated by a constant thickness body, having an elliptical leading edge, which is mounted perpendicular ...
Hubbartt, J., Kubendran, L., Mcmahon, H.
core   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Derivation and evaluation of an approximate analysis for three-dimensional viscous subsonic flow with large secondary velocities [PDF]

open access: yes
An approximate analysis is presented for calculating three-dimensional, low Mach number, laminar viscous flows in curved passages with large secondary flows and corner boundary layers.
Anderson, O. L.   +2 more
core   +1 more source

Lagrangian turbulence in the Adriatic Sea as computed from drifter data: effects of inhomogeneity and nonstationarity

open access: yes, 2003
The properties of mesoscale Lagrangian turbulence in the Adriatic Sea are studied from a drifter data set spanning 1990-1999, focusing on the role of inhomogeneity and nonstationarity.
A. Maurizi   +39 more
core   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy